These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11805237)

  • 1. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells.
    Kim KY; Shin HK; Choi JM; Hong KW
    J Pharmacol Exp Ther; 2002 Feb; 300(2):709-15. PubMed ID: 11805237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation.
    Kim MJ; Lee JH; Park SY; Hong KW; Kim CD; Kim KY; Lee WS
    Pharmacol Res; 2006 Oct; 54(4):261-7. PubMed ID: 16822680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of lipopolysaccharide-induced apoptosis by (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine, a benzopyran analog, in endothelial cells.
    Kim KY; Kim BG; Kim SO; Yoo SE; Kwak YG; Chae SW; Hong KW
    J Pharmacol Exp Ther; 2002 Feb; 300(2):535-42. PubMed ID: 11805214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.
    Lim JH; Woo JS; Shin YW
    Korean J Intern Med; 2009 Jun; 24(2):113-22. PubMed ID: 19543489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
    Nishio Y; Kashiwagi A; Takahara N; Hidaka H; Kikkawa R
    Horm Metab Res; 1997 Oct; 29(10):491-5. PubMed ID: 9405974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax.
    Haendeler J; Zeiher AM; Dimmeler S
    Eur J Pharmacol; 1996 Dec; 317(2-3):407-11. PubMed ID: 8997628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.
    Choi JM; Shin HK; Kim KY; Lee JH; Hong KW
    J Pharmacol Exp Ther; 2002 Mar; 300(3):787-93. PubMed ID: 11861782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax.
    Hu L; Sun Y; Hu J
    Eur J Pharmacol; 2010 Feb; 628(1-3):155-63. PubMed ID: 19962976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells.
    Messmer UK; Briner VA; Pfeilschifter J
    Kidney Int; 1999 Jun; 55(6):2322-37. PubMed ID: 10354280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
    Hattori Y; Suzuki K; Tomizawa A; Hirama N; Okayasu T; Hattori S; Satoh H; Akimoto K; Kasai K
    Cardiovasc Res; 2009 Jan; 81(1):133-9. PubMed ID: 18703532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.
    Shin HK; Kim YK; Kim KY; Lee JH; Hong KW
    Circulation; 2004 Mar; 109(8):1022-8. PubMed ID: 14967724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
    Nakamura K; Ikomi F; Ohhashi T
    J Vasc Res; 2006; 43(1):86-94. PubMed ID: 16286783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
    Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
    Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of cilostazol, a phosphodiesterase III inhibitor, on catecholamine secretion from cultured bovine adrenal chromaffin cells.
    Azuma M; Houchi H; Mizuta M; Kinoshita M; Teraoka K; Minakuchi K
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S29-32. PubMed ID: 12688393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction.
    Park SY; Lee SW; Shin HK; Chung WT; Lee WS; Rhim BY; Hong KW; Kim CD
    Arthritis Rheum; 2010 Mar; 62(3):732-41. PubMed ID: 20131233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells.
    Ota H; Eto M; Kano MR; Ogawa S; Iijima K; Akishita M; Ouchi Y
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1634-9. PubMed ID: 18556572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.
    Hashimoto A; Miyakoda G; Hirose Y; Mori T
    Atherosclerosis; 2006 Dec; 189(2):350-7. PubMed ID: 16545819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells.
    Wu SN; Liu SI; Huang MH
    Endocrinology; 2004 Mar; 145(3):1175-84. PubMed ID: 14645120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation.
    Hong KW; Kim KY; Shin HK; Lee JH; Choi JM; Kwak YG; Kim CD; Lee WS; Rhim BY
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1182-90. PubMed ID: 12807996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.